The approach provides an “off-the-shelf” way for researchers to compare oxytocin function across species, the team says.

But the alternatives, including living-brain biopsies, raise logistical and ethical questions, experts say.

The paper marks the second retraction for one of the co-authors.

Few studies have tracked how brain structure and function change across adulthood in people with autism. Carper and her colleagues are collecting data to fill this gap.

Experiments offer clues to why certain mutations are associated with autism in some people and not others.

The new resource aims to aid reproducibility in imaging research.

The findings add to the growing evidence that genes with disparate functions can play similar roles in brain development.

A shift in astrocyte secretions may explain the atypical firing patterns of neurons derived from people with fragile X syndrome.

The retracted studies mar hope for the drug’s use in depression.

Autistic children taking the drug showed improvements in some behaviors but not in their social skills.